Masimo (MASI) Non-Current Deffered Revenue (2010 - 2018)
Masimo's (MASI) quarterly Non-Current Deffered Revenue came in at $685000.0 in Q4 2018, up 189.03% year-on-year from $237000.0 in Q4 2017, and up 223.11% quarter-over-quarter from $212000.0 in Q1 2018.
Masimo (MASI) Non-Current Deffered Revenue (2010 - 2018) Analysis & Trends
Masimo's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $685000.0 for Q4 2018.
- On a quarterly basis, Non-Current Deffered Revenue rose 189.03% year-over-year to $685000.0 in Q4 2018; TTM through Dec 2018 was $685000.0, a 189.03% increase from a year earlier, with the FY2018 full-year figure at $685000.0, up 189.03% from the prior year.
- Non-Current Deffered Revenue climbed to $685000.0 in Q4 2018 per MASI's latest filing, from $212000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $25.3 million in Q4 2016 and bottomed at $212000.0 in Q1 2018.
- The 5-year median for Non-Current Deffered Revenue is $417000.0 (2015), against an average of $4.7 million.
- Across the five-year window, Non-Current Deffered Revenue soared 11156.62% in 2017 and slumped 99.16% in 2018, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $492000.0 in 2014, then slumped by 31.5% to $337000.0 in 2015, then surged by 7418.1% to $25.3 million in 2016, then plunged by 99.06% to $237000.0 in 2017, then surged by 189.03% to $685000.0 in 2018.
- Per Business Quant, the three latest MASI Non-Current Deffered Revenue figures stand at $685000.0 (Q4 2018), $212000.0 (Q1 2018), and $237000.0 (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 29, 2018 | 685,000.00 |
| Mar 31, 2018 | 212,000.00 |
| Dec 30, 2017 | 237,000.00 |
| Sep 30, 2017 | 261,000.00 |
| Jul 1, 2017 | 24.65 Mn |
| Apr 1, 2017 | 25.31 Mn |
| Dec 31, 2016 | 25.34 Mn |
| Jul 2, 2016 | 219,000.00 |
| Apr 2, 2016 | 258,000.00 |
| Jan 2, 2016 | 298,000.00 |
| Oct 3, 2015 | 337,000.00 |
| Jul 4, 2015 | 376,000.00 |
| Apr 4, 2015 | 417,000.00 |
| Jan 3, 2015 | 453,000.00 |
| Sep 27, 2014 | 492,000.00 |
| Jun 28, 2014 | 530,000.00 |
| Mar 29, 2014 | 569,000.00 |
| Dec 28, 2013 | 566,000.00 |
| Sep 28, 2013 | 563,000.00 |
| Jun 29, 2013 | 400,000.00 |